These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 15326069)

  • 1. The 1+1 trial: a prospective trial of a dual- versus a single-chamber implantable defibrillator in patients with slow ventricular tachycardias.
    Bänsch D; Steffgen F; Grönefeld G; Wolpert C; Böcker D; Mletzko RU; Schöls W; Seidl K; Piel M; Ouyang F; Hohnloser SH; Kuck KH
    Circulation; 2004 Aug; 110(9):1022-9. PubMed ID: 15326069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study.
    Friedman PA; McClelland RL; Bamlet WR; Acosta H; Kessler D; Munger TM; Kavesh NG; Wood M; Daoud E; Massumi A; Schuger C; Shorofsky S; Wilkoff B; Glikson M
    Circulation; 2006 Jun; 113(25):2871-9. PubMed ID: 16769912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and clinical relevance of slow ventricular tachycardia in implantable cardioverter-defibrillator recipients: an international multicenter prospective study.
    Sadoul N; Mletzko R; Anselme F; Bowes R; Schöls W; Kouakam C; Casteigneau G; Luise R; Iscolo N; Aliot E;
    Circulation; 2005 Aug; 112(7):946-53. PubMed ID: 16103252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphology discrimination criterion wavelet improves rhythm discrimination in single-chamber implantable cardioverter-defibrillators: Spanish Register of morphology discrimination criterion wavelet (REMEDIO).
    Toquero J; Alzueta J; Mont L; Lozano IF; Barrera A; Berruezo A; Castro V; Peña JL; Fidalgo ML; Brugada J
    Europace; 2009 Jun; 11(6):727-33. PubMed ID: 19411676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular tachycardias above the initially programmed tachycardia detection interval in patients with implantable cardioverter-defibrillators: incidence, prediction and significance.
    Bänsch D; Castrucci M; Böcker D; Breithardt G; Block M
    J Am Coll Cardiol; 2000 Aug; 36(2):557-65. PubMed ID: 10933372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with a new detection algorithm for differentiation of supraventricular from ventricular tachycardia in a dual-chamber defibrillator.
    Sinha AM; Stellbrink C; Schuchert A; Mox B; Jordaens L; Lamaison D; Gill J; Kaplan A; Merkely B;
    J Cardiovasc Electrophysiol; 2004 Jun; 15(6):646-52. PubMed ID: 15175058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of a new single-chamber ICD algorithm: discrimination of supraventricular and ventricular tachycardia based on vector timing and correlation.
    Corbisiero R; Lee MA; Nabert DR; Coman JA; Breiter DJ; Schwartz M; McKittrick E; Zhang Y
    Europace; 2006 Dec; 8(12):1057-61. PubMed ID: 17105781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of inappropriate therapy in implantable cardioverter-defibrillators: results of a prospective, randomized study of tachyarrhythmia detection algorithms.
    Theuns DA; Klootwijk AP; Goedhart DM; Jordaens LJ
    J Am Coll Cardiol; 2004 Dec; 44(12):2362-7. PubMed ID: 15607399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial clinical experience with a new arrhythmia detection algorithm in dual chamber implantable cardioverter defibrillators.
    Theuns D; Klootwijk AP; Kimman GP; Szili-Török T; Roelandt JR; Jordaens L
    Europace; 2001 Jul; 3(3):181-6. PubMed ID: 11467458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving SVT discrimination in single-chamber ICDs: a new electrogram morphology-based algorithm.
    Klein GJ; Gillberg JM; Tang A; Inbar S; Sharma A; Unterberg-Buchwald C; Dorian P; Moore H; Duru F; Rooney E; Becker D; Schaaf K; Benditt D;
    J Cardiovasc Electrophysiol; 2006 Dec; 17(12):1310-9. PubMed ID: 17096661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced specificity of a dual chamber ICD arrhythmia detection algorithm by rate stability criteria.
    Mletzko R; Anselme F; Klug D; Schoels W; Bowes R; Iscolo N; Nitzsché R; Sadoul N;
    Pacing Clin Electrophysiol; 2004 Aug; 27(8):1113-9. PubMed ID: 15305961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic strategies in inappropriate ICD therapy].
    Klein G; Korte T
    Herz; 2005 Nov; 30(7):619-24. PubMed ID: 16333588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of patients supplied with single-chamber or dual-chamber cardioverter defibrillators.
    Kolb C; Deisenhofer I; Schmieder S; Barthel P; Zrenner B; Karch MR; Schmitt C
    Pacing Clin Electrophysiol; 2006 Sep; 29(9):946-52. PubMed ID: 16981917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to avoid inappropriate therapy.
    Israel CW
    Curr Opin Cardiol; 2008 Jan; 23(1):65-71. PubMed ID: 18281830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arrhythmia detection in single- and dual-chamber implantable cardioverter defibrillators: the more leads, the better?
    Francia P; Balla C; Uccellini A; Cappato R
    J Cardiovasc Electrophysiol; 2009 Sep; 20(9):1077-82. PubMed ID: 19500231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of first ventricular tachycardia cycle length on rate of ventricular arrhythmia recurrence in patients with implantable cardioverter-defibrillator.
    Arya A; Haghjoo M; Nikoo MH; Dehghani MR; Fazelifar AF; Sadr-Ameli MA
    J Electrocardiol; 2006 Oct; 39(4):404-8. PubMed ID: 16895771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Frequent ventricular tachycardias: antiarrhythmic drug treatment or catheter ablation?].
    Tanner H; Hindricks G; Kottkamp H
    Herz; 2005 Nov; 30(7):613-8. PubMed ID: 16333587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-chamber implantable cardioverter defibrillators reduce clinical adverse events related to atrial fibrillation when compared with single-chamber defibrillators: a subanalysis of the DATAS trial.
    Ricci RP; Quesada A; Almendral J; Arribas F; Wolpert C; Adragao P; Zoni-Berisso M; Navarro X; DeSanto T; Grammatico A; Santini M;
    Europace; 2009 May; 11(5):587-93. PubMed ID: 19401341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.